CN1276775C - 一种治疗眼底出血症的中药及其制备方法 - Google Patents
一种治疗眼底出血症的中药及其制备方法 Download PDFInfo
- Publication number
- CN1276775C CN1276775C CN 200410038250 CN200410038250A CN1276775C CN 1276775 C CN1276775 C CN 1276775C CN 200410038250 CN200410038250 CN 200410038250 CN 200410038250 A CN200410038250 A CN 200410038250A CN 1276775 C CN1276775 C CN 1276775C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- treatment
- chinese medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 14
- 230000003287 optical effect Effects 0.000 title abstract description 18
- 208000032843 Hemorrhage Diseases 0.000 title abstract description 17
- 230000008569 process Effects 0.000 title description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 39
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 41
- 238000002360 preparation method Methods 0.000 claims description 39
- 208000037111 Retinal Hemorrhage Diseases 0.000 claims description 38
- 239000000796 flavoring agent Substances 0.000 claims description 34
- 235000019634 flavors Nutrition 0.000 claims description 34
- 239000008187 granular material Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 21
- 239000003610 charcoal Substances 0.000 claims description 20
- 239000002552 dosage form Substances 0.000 claims description 16
- 230000006837 decompression Effects 0.000 claims description 15
- 238000012545 processing Methods 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 9
- 229940126678 chinese medicines Drugs 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 239000011812 mixed powder Substances 0.000 claims description 9
- -1 60 °C of oven dry Substances 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000007901 soft capsule Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 240000008415 Lactuca sativa Species 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 208000030533 eye disease Diseases 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 235000012045 salad Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000009495 sugar coating Methods 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 241000207929 Scutellaria Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 25
- 201000010099 disease Diseases 0.000 abstract description 15
- 150000001875 compounds Chemical class 0.000 abstract description 5
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 2
- 244000286838 Eclipta prostrata Species 0.000 abstract description 2
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000195955 Equisetum hyemale Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 241000735234 Ligustrum Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 56
- 239000008280 blood Substances 0.000 description 56
- 210000004185 liver Anatomy 0.000 description 40
- 210000001508 eye Anatomy 0.000 description 25
- 230000004438 eyesight Effects 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 15
- 230000023597 hemostasis Effects 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 210000001525 retina Anatomy 0.000 description 8
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 210000000232 gallbladder Anatomy 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 208000004644 retinal vein occlusion Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 206010057267 Periphlebitis Diseases 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 208000001297 phlebitis Diseases 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 201000010183 Papilledema Diseases 0.000 description 5
- 206010033708 Papillitis Diseases 0.000 description 5
- 208000034698 Vitreous haemorrhage Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 201000002166 optic papillitis Diseases 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000201295 Euphrasia Species 0.000 description 4
- 206010038491 Renal papillary necrosis Diseases 0.000 description 4
- 208000017442 Retinal disease Diseases 0.000 description 4
- 206010038923 Retinopathy Diseases 0.000 description 4
- 206010053615 Thermal burn Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 208000013403 hyperactivity Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000004304 visual acuity Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 3
- 241000083513 Punctum Species 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000009978 visual deterioration Effects 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000013557 Plantaginaceae Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- QXJJQWWVWRCVQT-UHFFFAOYSA-K calcium;sodium;phosphate Chemical compound [Na+].[Ca+2].[O-]P([O-])([O-])=O QXJJQWWVWRCVQT-UHFFFAOYSA-K 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 201000005667 central retinal vein occlusion Diseases 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 210000004127 vitreous body Anatomy 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 241000195952 Equisetaceae Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241001518821 Typha orientalis Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
□一般资料 | |||||||||||||||
病名 | 性别 | 年龄 | 眼别 | ||||||||||||
眼底血症347例 | 男231 | 女143 | 18~2030 | 21~4079 | 41~60138 | 61以上127 | 左139 | 右161 | 双眼85 | ||||||
□分类 | |||||||||||||||
视网膜静脉阻塞 | 视网膜静脉周围炎 | 糖尿病视网膜病变 | 黄斑出血 | 视盘血管炎 | 玻璃体积血 | 中渗 | 高血压视网膜病变 | ||||||||
例数眼数 | 9292 | 6498 | 1938 | 78112 | 3434 | 3737 | 4856 | 22 |
□治疗结果 | |||||
结果分类 | 治愈眼(%) | 显效眼(%) | 有效眼(%) | 无效眼(%) | 总有效率(%) |
视网膜静脉阻塞 | 11(11.96%) | 31(33.7%) | 35(38.04%) | 15(16.3%) | 83.64% |
视网膜静脉周围炎 | 16(16.32%) | 30(30.62%) | 31(31.63%) | 21(21.43%) | 78.57% |
糖尿病视网膜病变 | 10(26.32%) | 10(26.32%) | 12(31.57%) | 6(15.79%) | 84.21% |
高血压视网膜病变 | 1(50%) | 00 | 00 | 1(50%) | 50% |
视盘血管炎 | 10(29.41%) | 10(29.41%) | 9(26.47%) | 5(14.71%) | 85.29% |
玻璃体出血 | 10(27.03% | 9(24.32%) | 11(29.73%) | 7(18.72%) | 81.80% |
黄斑出血 | 17(15.18%) | 31(27.68%) | 42(37.5%) | 22(19.64%) | 80.36% |
中渗 | 9(16.07%) | 17(30.36%) | 18(32.14%) | 12(21.43%) | 78.57% |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410038250 CN1276775C (zh) | 2003-05-21 | 2004-05-18 | 一种治疗眼底出血症的中药及其制备方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03108059 CN1451422A (zh) | 2003-05-21 | 2003-05-21 | 一种治疗眼底出血症的中药及其制备方法 |
CN03108059.6 | 2003-05-21 | ||
CN 200410038250 CN1276775C (zh) | 2003-05-21 | 2004-05-18 | 一种治疗眼底出血症的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1544074A CN1544074A (zh) | 2004-11-10 |
CN1276775C true CN1276775C (zh) | 2006-09-27 |
Family
ID=34378660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410038250 Expired - Lifetime CN1276775C (zh) | 2003-05-21 | 2004-05-18 | 一种治疗眼底出血症的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1276775C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102151312B (zh) * | 2011-03-22 | 2013-03-13 | 孙丰卿 | 一种治疗玻璃体积血的药物及其制备方法 |
CN102319400B (zh) * | 2011-09-26 | 2012-11-28 | 西安碑林药业股份有限公司 | 一种用于凉血止血、滋阴化瘀、养肝明目的中药组合物及其制备方法 |
CN102319398B (zh) * | 2011-09-26 | 2012-11-28 | 西安碑林药业股份有限公司 | 一种和血明目中药组合物及其制备方法 |
CN104800559B (zh) * | 2015-04-26 | 2016-01-06 | 美亚药业海安有限公司 | 一种治疗眼底出血的药物 |
CN105596625A (zh) * | 2016-02-03 | 2016-05-25 | 王海凤 | 一种治疗视网膜血管炎的中药制剂 |
CN114588236B (zh) * | 2020-12-03 | 2023-10-27 | 西安碑林药业股份有限公司 | 组合物在制备药物中的用途 |
-
2004
- 2004-05-18 CN CN 200410038250 patent/CN1276775C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1544074A (zh) | 2004-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1245187C (zh) | 一种治疗由脏腑病所致眼病的药物 | |
CN1768812A (zh) | 一种用于除湿止痒的药物组合物及其制备方法和用途 | |
CN1915399A (zh) | 治疗高血压、高血脂、肥胖症及更年期综合症的制剂及其制备方法 | |
CN1742993A (zh) | 治疗妇科疾病的中成药及其制备方法 | |
CN101062377A (zh) | 一种通经活络、祛风散寒、消炎止痛的膏药及其制备方法 | |
CN1267144C (zh) | 复方消渴清糖降脂制剂及其制备方法 | |
CN1726991A (zh) | 治疗妇女痛经、***、产后虚弱的药物及其制备方法 | |
CN1297291C (zh) | 一种戒除毒瘾的药物及其制备方法 | |
CN1724022A (zh) | 防治子宫异常出血病的中药复方制剂及其生产方法 | |
CN1843435A (zh) | 金蝉止痒制剂及其制备方法 | |
CN1276775C (zh) | 一种治疗眼底出血症的中药及其制备方法 | |
CN1191082C (zh) | 一种治疗脂肪肝的中药组合物及其制备方法 | |
CN1451422A (zh) | 一种治疗眼底出血症的中药及其制备方法 | |
CN1299731C (zh) | 一种治疗眼疾近视、消除视疲劳症状的中药及其制备方法 | |
CN1927331A (zh) | 一种治疗慢性心力衰竭的中药制剂 | |
CN1706435A (zh) | 一种治疗经前期紧张综合征的中药组合物及其制备方法 | |
CN1232279C (zh) | 一种降血脂的中药 | |
CN101036722A (zh) | 一种缓解疲劳、改善男性更年期综合征的保健食品及制备 | |
CN1453019A (zh) | 一种治疗中老年眼部疾病的中药及其制备方法 | |
CN1559495A (zh) | 鹿胎颗粒中药制剂及生产工艺 | |
CN1232267C (zh) | 用于治疗脑血管疾病的组合物及其制备方法和应用 | |
CN1544072A (zh) | 一种治疗中老年眼部疾病的中药及其制备方法 | |
CN1857495A (zh) | 一种治疗痛证的中药复方制剂及其制备方法 | |
CN1211111C (zh) | 一种降血脂中药 | |
CN1282470C (zh) | 一种抗抑郁中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Xiaohua Inventor after: Han Yong Inventor after: Shi Li Inventor after: Yang Li Inventor before: Huang Xiaohua Inventor before: Han Yong Inventor before: Shi Li |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG XIAOHUA HAN YONG SHI LI TO: HUANG XIAOHUA HAN YONG SHI LI YANG LI |
|
DD01 | Delivery of document by public notice |
Addressee: Qu Jinxue Document name: Notice of termination |
|
DD01 | Delivery of document by public notice |
Addressee: Qu Jinxue Document name: Notification of Termination of Procedure |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060927 |